Suppr超能文献

精氨酸酶 1 和精氨酸酶 2 的变异与哮喘、哮喘严重程度以及β2 激动剂和类固醇反应有关。

Arginase 1 and arginase 2 variations associate with asthma, asthma severity and beta2 agonist and steroid response.

机构信息

Department of Epidemiology, University Medical Center Groningen, The Netherlands.

出版信息

Pharmacogenet Genomics. 2010 Mar;20(3):179-86. doi: 10.1097/FPC.0b013e328336c7fd.

Abstract

RATIONALE

Arginase probably plays an important role in asthma development, severity and progression. Polymorphisms in arginase 1 and arginase 2 genes have been associated with childhood asthma and FEV1 reversibility to beta2 agonists.

OBJECTIVES

We investigated the association between arginase 1 and arginase 2 polymorphisms and adult asthma, asthma severity and treatment response in a longitudinal cohort of 200 asthma patients.

METHODS

Patients were studied during 1962-1975 and reexamined during 1990-1999, together with their families. Longitudinal data on lung function and treatment were extracted from medical records. Associations between haplotype-tagging polymorphisms in arginase 1 (n=3) and arginase 2 (n=8) and asthma, asthma severity, acute response to bronchodilators and chronic response to inhaled corticosteroids were analyzed.

MEASUREMENTS AND MAIN RESULTS

Two polymorphisms in arginase 2 (rs17249437 and rs3742879) were associated with asthma and with more severe airway obstruction. Increased airway hyperresponsiveness and lower beta2 agonist reversibility, but not anticholinergic reversibility, were associated with both arginase 1 and arginase 2. Inhaled corticosteroids slowed down the annual FEV1 decline, which was significantly less effective in homozygote carriers of the C-allele of the arginase 1 polymorphism, rs2781667.

CONCLUSION

We show that previously reported associations between arginase polymorphisms and childhood asthma are also present in adult asthma and the previously found associations with lower reversibility are specific for beta2 agonists. Furthermore, we identified associations of arginase 1 and arginase 2 genes with asthma severity, as reflected by a lower lung function, more severe airway hyperresponsiveness, and less long-term response to inhaled corticosteroids. Studies on the functionality of the polymorphisms are warranted to further unravel the complex mechanisms underlying these observations.

摘要

背景

精氨酸酶可能在哮喘的发生、严重程度和进展中发挥重要作用。精氨酸酶 1 和精氨酸酶 2 基因的多态性与儿童哮喘和对β2 激动剂的 FEV1 可逆性有关。

目的

我们在一个 200 名哮喘患者的纵向队列中研究了精氨酸酶 1 和精氨酸酶 2 基因多态性与成人哮喘、哮喘严重程度和治疗反应之间的关系。

方法

患者在 1962-1975 年期间进行研究,并在 1990-1999 年期间与他们的家人一起重新检查。从病历中提取关于肺功能和治疗的纵向数据。分析精氨酸酶 1(n=3)和精氨酸酶 2(n=8)的标签单倍型多态性与哮喘、哮喘严重程度、对支气管扩张剂的急性反应和对吸入性皮质类固醇的慢性反应之间的关系。

测量和主要结果

精氨酸酶 2 中的两个多态性(rs17249437 和 rs3742879)与哮喘和更严重的气道阻塞有关。气道高反应性增加和β2 激动剂的可逆性降低,但不是抗胆碱能药物的可逆性降低,与精氨酸酶 1 和精氨酸酶 2 都有关。吸入皮质类固醇可减缓每年的 FEV1 下降速度,但在精氨酸酶 1 多态性 rs2781667 的 C 等位基因纯合子携带者中效果明显降低。

结论

我们表明,先前报道的精氨酸酶多态性与儿童哮喘之间的关联也存在于成人哮喘中,先前发现的与较低的可逆性有关的关联是β2 激动剂特异性的。此外,我们还发现精氨酸酶 1 和精氨酸酶 2 基因与哮喘严重程度有关,表现在肺功能较低、气道高反应性更严重、对吸入性皮质类固醇的长期反应较差。有必要对这些多态性的功能进行研究,以进一步阐明这些观察结果背后的复杂机制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验